Novamind and Wholeness Center partner on a psychedelic therapy protocol for frontline healthcare workers
Group ketamine therapy for healthcare workers with Covid-based stress & trauma led by Dr. Scott Shannon and Dr. Reid Robison
Learn morePsychedelic medicine,
here and now
A growing network of psychiatry clinics, research sites and therapeutic retreats specialized in psychedelic medicine
Watch the videoPsychedelic medicine,
here and now
A growing network of psychiatry clinics, research sites and therapeutic retreats specialized in psychedelic medicine
Watch the videoOur focus
Empowering healing
Clinical care
Psychiatry clinics specialized in psychedelic medicine
Clinical research
Psychedelic clinical trials and protocol development
Therapeutic retreats
Legal, medically supervised psychedelic experiences
Our network
Global access to psychedelic
medicine
Our network
Global access to psychedelic medicine
Providing access to innovative, evidence based mental healthcare
Following all state and federal regulations regarding the use of psychedelics
Enabling mental health breakthroughs through psychedelic research
Our healthcare divisions
Integrative mental healthcare
A network of psychiatry clinics and therapeutic retreats dedicated to healing people through psychedelic medicine and alternative mental health modalities.
Learn more
Enabling mental health breakthroughs
A leading clinical research organization dedicated to psychedelic medicine and emerging mental health therapies.
Learn moreTherapeutic retreats
Circadia Center – Costa Rica
Novamind strategic investment
A psychedelic therapeutic retreat offering legal, medically supervised experiences.
Learn moreSynthesis Institute – Netherlands
Novamind strategic investment
A legal, medically supervised psychedelic retreat centre in Amsterdam.
Learn morePress releases
July 21, 2021
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
July 08, 2021
Novamind Selected as Research Site for Bionomics’ PTSD Clinical Trial
June 30, 2021
Novamind Launches Psychedelic Therapy Frontiers Podcast
June 23, 2021
Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer
